BCC022 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults, Children
Study Details
Full Title
BCC022: Phase II Trial of Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma
Principal Investigator
Jessica M. Sun, MD
Pediatric Hematology-Oncology Specialist
Protocol Number
IRB:
PRO00118933
NCT:
NCT06540963
Phase
Phase II
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment